ZhongOu Fund Appoints Tech Specialist Dai Yunfeng to Succeed Ge Lan as Manager of Mingrui New Starting Fund

Deep News
04/29

On April 29, ZhongOu Fund announced that Dai Yunfeng will replace Ge Lan as the fund manager of ZhongOu Mingrui New Starting Fund. The latest quarterly report shows the fund's top ten holdings are primarily concentrated in electronics, power equipment, and telecommunications sectors. The newly appointed manager Dai Yunfeng is a member of ZhongOu Fund's technology team with 13 years of securities industry experience and 8 years in investment management, specializing in technology and manufacturing sectors. Following this change, Ge Lan will continue to manage two healthcare-themed funds: ZhongOu Healthcare and ZhongOu Healthcare Innovation. Since its inception, ZhongOu Healthcare A has achieved a return of 94.71%, compared to its benchmark return of 8.9%. ZhongOu Healthcare Innovation A has gained 44.34% since establishment, versus its benchmark's -1.29%. Market analysts note that deepening professional specialization helps fund managers focus on their core expertise and potentially enhance investment management capabilities. Recent regulatory guidelines emphasize accelerating the development of integrated, multi-strategy investment research systems and supporting team-based management approaches to strengthen research capabilities. Investment funds carry risks, and investors should exercise caution. Past performance does not guarantee future results. Investors should review legal documents and understand risk characteristics before making investment decisions. Mixed funds like ZhongOu Healthcare and ZhongOu Mingrui New Starting typically show higher risk-return profiles than bond or money market funds but lower than equity funds. Equity funds such as ZhongOu Healthcare Innovation generally demonstrate higher risk-return characteristics than bond, money market, or mixed funds. Fee structures vary by share class and holding period, with detailed schedules provided in fund documents.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10